Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$55.7 - $145.79 $96,472 - $252,508
-1,732 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $2,183 - $2,882
15 Added 0.87%
1,732 $252,000
Q2 2021

Aug 11, 2021

SELL
$134.22 - $202.37 $46,305 - $69,817
-345 Reduced 16.73%
1,717 $336,000
Q1 2021

May 13, 2021

BUY
$140.25 - $196.86 $48,386 - $67,916
345 Added 20.09%
2,062 $373,000
Q3 2020

Nov 12, 2020

BUY
$87.44 - $125.0 $150,134 - $214,625
1,717 New
1,717 $214,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.